Host: |
Rabbit |
Applications: |
CM/ELISA/ICC/IF/IHC/IP/WB |
Reactivity: |
Human |
Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Short Description: |
Rabbit polyclonal antibody anti-CXCR5 (320-370) is suitable for use in Confocal Microscopy, ELISA, Immunocytochemistry, Immunofluorescence, Immunohistochemistry, Immunoprecipitation and Western Blot research applications. |
Clonality: |
Polyclonal |
Conjugation: |
FITC |
Isotype: |
IgG |
Purification: |
Affinity Purified |
Concentration: |
0.50-1.20 µg/µl |
Dilution Range: |
WB: 1:500DB: 1:10, 000ELISA: 1:10, 000IP: 1:200 |
Storage Instruction: |
Store at-20°C for long term storage. Avoid freeze-thaw cycles. |
Gene Symbol: |
CXCR5 |
Gene ID: |
643 |
Uniprot ID: |
CXCR5_HUMAN |
Immunogen Region: |
320-370 |
Immunogen: |
Synthetic peptide taken within amino acid region 320-370 on human Chemokine (C-X-C motif) receptor 5 protein. |
Tissue Specificity | Expression in mature B-cells and Burkitt lymphoma cells. |
Function | Cytokine receptor that binds to B-lymphocyte chemoattractant (BLC). Involved in B-cell migration into B-cell follicles of spleen and Peyer patches but not into those of mesenteric or peripheral lymph nodes. May have a regulatory function in Burkitt lymphoma (BL) lymphomagenesis and/or B-cell differentiation. |
Protein Name | C-X-C Chemokine Receptor Type 5Cxc-R5Cxcr-5Burkitt Lymphoma Receptor 1Monocyte-Derived Receptor 15Mdr-15Cd Antigen Cd185 |
Database Links | Reactome: R-HSA-380108Reactome: R-HSA-418594 |
Cellular Localisation | Cell MembraneMulti-Pass Membrane Protein |
Alternative Antibody Names | Anti-C-X-C Chemokine Receptor Type 5 antibodyAnti-Cxc-R5 antibodyAnti-Cxcr-5 antibodyAnti-Burkitt Lymphoma Receptor 1 antibodyAnti-Monocyte-Derived Receptor 15 antibodyAnti-Mdr-15 antibodyAnti-Cd Antigen Cd185 antibodyAnti-CXCR5 antibodyAnti-BLR1 antibodyAnti-MDR15 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance